Sodium chloride

Generic Name: Sodium chloride

Brand Names: Amphenol-40, As 3, Bi-peglyte, Bicart, Bss, Bss Ophthalmic Solution, Cardioplegic, Citrasate, Clinimix E 2.75/5, Colyte, Corvatrol, Dextrose and Electrolyte No. 75, Dianeal, Dianeal Low Calcium 1.5, Dianeal Pd-2/1.5, Extraneal, Eye Stream, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Golytely, H.E.L.P.bicel, Hemosate Ultra, Hespan, Hizentra, Hyperlyte, Intersol, Isolyte S, Isolyte S pH 7.4, Isoplate, Lactate 1-2-3, Lactated Ringers, Menopur, Moviprep, Muro 128, Naturalyte, Normosol-M, Normosol-R, Nulytely, Nxstage Pureflow, P-Care M, P-Care MG, P-care, P-care X, Peglyte, Phoxillum, Physiolyte, Physioneal 40, Physiosol, Plasma-lyte, Plasma-lyte 148, Plasma-lyte 148 In 5 % Dextrose, Plasma-lyte R, Plasmalyte A, Plegisol, Plenvu, Prismasol, Procalamine 3, Ringers, Sag-M, Sclerodex, Suflave, Tis-U-sol

Drug Type: Small Molecule

Chemical Formula: ClNa

CAS Number: 7647-14-5

Unique Ingredient Identifier: 451W47IQ8X

Background: Sodium chloride, also known as salt, common salt, table salt or halite, is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions. Sodium chloride is the primary salt in seawater and in the extracellular fluid of many multicellular organisms. It is listed on the World Health Organization Model List of Essential...

Indication: This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives.

Associated Conditions: Allergic Rhinitis (AR), Corneal Edema, Dehydration, Dehydration Hypertonic, Fluid Loss, Hemodilution, Hypokalemia, Hyponatremia, Hypotonic Dehydration, Hypovolaemia, Increase in Intracranial Pressure (ICP), Increased Intra Ocular Pressure (IOP), Inflammation of the Nasal Mucosa, Isotonic Dehydration, Metabolic Acidosis, Nasal Congestion, Nasal irritation, Oliguria caused by Acute Renal Failure (ARF), Potassium deficiency, Sinusitis, Skin Irritation, Sodium Depletion, Dryness of the nose, Hypochloremic state, Mild Metabolic acidosis, Mild, moderate Metabolic Acidosis

Associated Therapies: Electrolyte replacement, Fluid replacement therapy, Heart-Lung-Machine, Oral rehydration therapy, Parenteral Nutrition, Parenteral rehydration therapy, Peritoneal dialysis therapy, Plasma Volume Replacement, Regional Citrate Anticoagulation (RCA), Renal Replacement Therapies, Urine alkalinization therapy, Wound irrigation therapy, Ear wax removal, Fluid and electrolyte maintenance therapy, Increased renal excretion of toxic substances, Maintenance source of fluid and electrolytes, Parenteral drug administration, Reducing brain mass

Clinical Trials

Ophthalmologic Examinations After Infusion of ZK200775

Phase 1

Completed

Conditions: Visual Acuity

Interventions: Drug: Sodium Chloride
Drug: ZK200775

First Posted Date: 2009-10-21

Last Posted Date: 2009-10-21

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 18

Registration Number: NCT00999284

Locations: 🇩🇪
Charité Unviversitätsmedizin Berlin, Augenklinik Campus Virchow-Klinikum, Berlin, Germany

Bicarbonate in Cardiac Surgery

Phase 2

Terminated

Conditions: Acute Kidney Injury

Interventions: Drug: Sodium Bicarbonate
Drug: Sodium Chloride

First Posted Date: 2009-04-09

Last Posted Date: 2012-08-01

Lead Sponsor: Austin Health

Target Recruit Count: 427

Registration Number: NCT00878956

Locations: 🇳🇿
Waikato Hospital, Hamilton, New Zealand
🇦🇺
Austin Hospital, Melbourne, Victoria, Australia
🇳🇿
Auckland City Hospital, Auckland, New Zealand

and more 1 locations

Steroid Injection Treatment of Carpal Tunnel Syndrome

Phase 2

Completed

Conditions: Carpal Tunnel Syndrome

Interventions: Drug: Methylprednisolone 40 mg
Drug: Methylprednisolone 80 mg
Drug: Sodium chloride

First Posted Date: 2008-12-11

Last Posted Date: 2012-04-04

Lead Sponsor: Region Skane

Target Recruit Count: 112

Registration Number: NCT00806871

Locations: 🇸🇪
Ortopediska kliniken, sjukvårdsorganisationen Hässleholm/CSK, Hässleholm, Sweden

Bicarbonate and Lipocalin in Systemic Inflammatory Response Syndrome (SIRS) Study

Phase 2

Completed

Conditions: Systemic Inflammatory Response Syndrome
Oliguria
Renal Impairment

Interventions: Drug: Sodium bicarbonate
Drug: Sodium chloride

First Posted Date: 2008-06-30

Last Posted Date: 2014-06-30

Lead Sponsor: Austin Health

Target Recruit Count: 70

Registration Number: NCT00706771

Locations: 🇦🇺
Austin Hospital, Heidelberg, Melbourne, Victoria, Australia
🇦🇺
Royal Melbourne Hospital, Melbourne, Victoria, Australia

Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection

Phase 4

Completed

Conditions: Emergent Coronary Procedure

Interventions: Drug: Sodium bicarbonate
Drug: Sodium Chloride

First Posted Date: 2008-06-18

Last Posted Date: 2010-07-20

Lead Sponsor: Osaka General Medical Center

Target Recruit Count: 59

Registration Number: NCT00700375

Locations: 🇯🇵
Osaka General Medical Center, Osaka, Japan

Organ Donation and Hydrocortisone Treatment

Not Applicable

Terminated

Conditions: Brain Death

Interventions: Drug: hydrocortisone
Drug: sodium chloride

First Posted Date: 2008-05-09

Last Posted Date: 2015-04-06

Lead Sponsor: Kuopio University Hospital

Target Recruit Count: 38

Registration Number: NCT00675272

Locations: 🇫🇮
Kuopio University Hospital, Kuopio, Finland
🇫🇮
Tampere University Hospital, Tampere, Finland

Sodium Bicarbonate in Cardiac Surgery Study

Phase 2

Terminated

Conditions: Cardiac Surgery
Cardiopulmonary Bypass

Interventions: Drug: Sodium Bicarbonate
Drug: Sodium Chloride

First Posted Date: 2008-05-06

Last Posted Date: 2012-08-01

Lead Sponsor: Austin Health

Target Recruit Count: 350

Registration Number: NCT00672334

Locations: 🇦🇺
Austin Health, Melbourne, Victoria, Australia
🇩🇪
Charité University Medicine, Berlin, Germany
🇨🇦
University of Alberta, Edmonton, Alberta, Canada

and more 1 locations

Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.

Phase 4

Completed

Conditions: Contrast Induced Nephropathy

Interventions: Drug: sodium chloride
Drug: sodium bicarbonate

First Posted Date: 2008-03-20

Last Posted Date: 2010-11-30

Lead Sponsor: Arcispedale Santa Maria Nuova-IRCCS

Target Recruit Count: 599

Registration Number: NCT00639912

Locations: 🇮🇹
Arcispedale S. Maria Nuova, Reggio Emilia, Emilia-Romagna, Italy
🇮🇹
Dipartimento di Cardiologia, Ospedale di Lavagna, Lavagna, Genova, Italy
🇮🇹
Azienda Ospedaliera Universitaria S. Anna, Ferrara, Emilia-romagna, Italy

and more 2 locations

A Randomised Controlled Trial of Iodide Supplementation in Preterm Infants Follow-up at 2 Years

Phase 4

Completed

Conditions: Transient Hypothyroxinemia

Interventions: Drug: Sodium Chloride
Drug: sodium iodide

First Posted Date: 2008-03-18

Last Posted Date: 2015-05-18

Lead Sponsor: University of Oxford

Target Recruit Count: 1275

Registration Number: NCT00638092

Locations: 🇬🇧
Ninewells Hospital and Medical School, Dundee, Tayside, United Kingdom
🇬🇧
Royal Maternity Hospital, Belfast, United Kingdom
🇬🇧
Heartlands Hospital, Birmingham, United Kingdom

and more 16 locations

Study : LEVOBUPIVACAINE Versus Placebo

Phase 3

Completed

Conditions: Pain

Interventions: Drug: chirocaine (Levobupivacaine)
Drug: sodium chloride

First Posted Date: 2008-02-22

Last Posted Date: 2010-09-16

Lead Sponsor: Centre Hospitalier Universitaire de Saint Etienne

Target Recruit Count: 140

Registration Number: NCT00621907

Locations: 🇫🇷
University Hospital, Saint-Etienne, France

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy